Connection

Peter Kalivas to Brain

Back to Details
This is a "connection" page, showing publications Peter Kalivas has written about Brain.
Peter Kalivas
Connection Strength
3.734
Brain
  1. Metaplasticity at the addicted tetrapartite synapse: A common denominator of drug induced adaptations and potential treatment target for addiction. Neurobiol Learn Mem. 2018 10; 154:97-111.
    View in: PubMed
    Score: 0.280
  2. Synaptic plasticity mediating cocaine relapse requires matrix metalloproteinases. Nat Neurosci. 2014 Dec; 17(12):1655-7.
    View in: PubMed
    Score: 0.222
  3. The story of glutamate in drug addiction and of N-acetylcysteine as a potential pharmacotherapy. JAMA Psychiatry. 2013 Sep; 70(9):895-7.
    View in: PubMed
    Score: 0.206
  4. Getting to the core of addiction: hatching the addiction egg. Nat Med. 2012 Apr 05; 18(4):502-3.
    View in: PubMed
    Score: 0.187
  5. Use of vivo-morpholinos for control of protein expression in the adult rat brain. J Neurosci Methods. 2012 Jan 30; 203(2):354-60.
    View in: PubMed
    Score: 0.181
  6. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009 May 15; 65(10):841-5.
    View in: PubMed
    Score: 0.149
  7. Brain norepinephrine rediscovered in addiction research. Biol Psychiatry. 2008 Jun 01; 63(11):1005-6.
    View in: PubMed
    Score: 0.143
  8. Neurotensin in the ventral pallidum increases extracellular gamma-aminobutyric acid and differentially affects cue- and cocaine-primed reinstatement. J Pharmacol Exp Ther. 2008 May; 325(2):556-66.
    View in: PubMed
    Score: 0.140
  9. Neurobiology of cocaine addiction: implications for new pharmacotherapy. Am J Addict. 2007 Mar-Apr; 16(2):71-8.
    View in: PubMed
    Score: 0.131
  10. Animal models and brain circuits in drug addiction. Mol Interv. 2006 Dec; 6(6):339-44.
    View in: PubMed
    Score: 0.129
  11. Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity. Brain Res. 2007 Jan 05; 1127(1):26-35.
    View in: PubMed
    Score: 0.128
  12. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005 Aug; 162(8):1403-13.
    View in: PubMed
    Score: 0.117
  13. Recent understanding in the mechanisms of addiction. Curr Psychiatry Rep. 2004 Oct; 6(5):347-51.
    View in: PubMed
    Score: 0.111
  14. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl). 2003 Jul; 168(1-2):44-56.
    View in: PubMed
    Score: 0.100
  15. Predisposition to addiction: pharmacokinetics, pharmacodynamics, and brain circuitry. Am J Psychiatry. 2003 Jan; 160(1):1-2.
    View in: PubMed
    Score: 0.098
  16. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date. Drugs. 2020 Oct; 80(15):1509-1524.
    View in: PubMed
    Score: 0.084
  17. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J Neurosci. 2000 Aug 15; 20(16):6210-7.
    View in: PubMed
    Score: 0.083
  18. The monoamine neurons of the rat brain preferentially express a splice variant of alpha1B subunit of the N-type calcium channel. J Neurochem. 1999 Oct; 73(4):1718-23.
    View in: PubMed
    Score: 0.078
  19. Regional distribution and cellular localization of gamma-aminobutyric acid subtype 1 receptor mRNA in the rat brain. J Comp Neurol. 1999 May 03; 407(2):166-82.
    View in: PubMed
    Score: 0.076
  20. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998 Jun-Jul; 51(1-2):141-53.
    View in: PubMed
    Score: 0.071
  21. A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol. 1998; 12(1):49-53.
    View in: PubMed
    Score: 0.069
  22. High and low behavioral response to novelty is associated with differences in neurotensin and substance P content. Ann N Y Acad Sci. 1996 Mar 22; 780:164-7.
    View in: PubMed
    Score: 0.061
  23. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend. 1995 Feb; 37(2):95-100.
    View in: PubMed
    Score: 0.057
  24. Neuroanatomy and neurochemical mechanisms of time-dependent sensitization. Toxicol Ind Health. 1994 Jul-Oct; 10(4-5):369-86.
    View in: PubMed
    Score: 0.054
  25. Astrocytic dysfunction and addiction: consequences of impaired glutamate homeostasis. Neuroscientist. 2014 Dec; 20(6):610-22.
    View in: PubMed
    Score: 0.053
  26. Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse. 1993 May; 14(1):10-5.
    View in: PubMed
    Score: 0.050
  27. Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann N Y Acad Sci. 1992 Jun 28; 654:128-35.
    View in: PubMed
    Score: 0.047
  28. Brain region-specific gene expression changes after chronic intermittent ethanol exposure and early withdrawal in C57BL/6J mice. Addict Biol. 2012 Mar; 17(2):351-64.
    View in: PubMed
    Score: 0.045
  29. Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis. J Pharmacol Exp Ther. 1990 Aug; 254(2):711-9.
    View in: PubMed
    Score: 0.042
  30. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther. 1990 May; 253(2):858-66.
    View in: PubMed
    Score: 0.041
  31. Group II metabotropic glutamate receptors (mGlu2/3) in drug addiction. Eur J Pharmacol. 2010 Aug 10; 639(1-3):115-22.
    View in: PubMed
    Score: 0.041
  32. Glutamate and reinstatement. Curr Opin Pharmacol. 2009 Feb; 9(1):59-64.
    View in: PubMed
    Score: 0.037
  33. Neuronal pentraxins modulate cocaine-induced neuroadaptations. J Pharmacol Exp Ther. 2009 Jan; 328(1):183-92.
    View in: PubMed
    Score: 0.037
  34. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther. 1988 May; 245(2):485-92.
    View in: PubMed
    Score: 0.036
  35. Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J Neurochem. 1988 May; 50(5):1498-504.
    View in: PubMed
    Score: 0.036
  36. Enkephalin modulation of A10 dopamine neurons: a role in dopamine sensitization. Ann N Y Acad Sci. 1988; 537:405-14.
    View in: PubMed
    Score: 0.035
  37. Sexual refractoriness and locomotion effects on brain monoamines in the male rat. Physiol Behav. 1987; 41(6):563-9.
    View in: PubMed
    Score: 0.032
  38. Homer proteins: implications for neuropsychiatric disorders. Curr Opin Neurobiol. 2006 Jun; 16(3):251-7.
    View in: PubMed
    Score: 0.031
  39. Neuroanatomical site specific modulation of spontaneous motor activity by neurotensin. Eur J Pharmacol. 1982 Mar 26; 78(4):471-4.
    View in: PubMed
    Score: 0.023
  40. Neuroanatomical sites of action of neurotensin. Ann N Y Acad Sci. 1982; 400:307-18.
    View in: PubMed
    Score: 0.023
  41. Extrasynaptic therapeutic targets in substance use and stress disorders. Trends Pharmacol Sci. 2022 01; 43(1):56-68.
    View in: PubMed
    Score: 0.023
  42. Circuit selectivity in drug versus natural reward seeking behaviors. J Neurochem. 2021 06; 157(5):1450-1472.
    View in: PubMed
    Score: 0.022
  43. Neuroanatomical dissociation of thyrotropin-releasing hormone induced shaking behavior and thermogenic mechanisms. Regul Pept. 1981 Feb; 1(5):335-45.
    View in: PubMed
    Score: 0.021
  44. Thyrotropin-releasing hormone: neurogenesis of actions in the pentobarbital narcotized rat. J Pharmacol Exp Ther. 1980 Feb; 212(2):203-10.
    View in: PubMed
    Score: 0.020
  45. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity. J Pharmacol Exp Ther. 1992 May; 261(2):811-8.
    View in: PubMed
    Score: 0.012
  46. Role of perisynaptic parameters in neurotransmitter homeostasis--computational study of a general synapse. Synapse. 2012 Jul; 66(7):608-21.
    View in: PubMed
    Score: 0.012
  47. Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther. 1991 Nov; 259(2):916-24.
    View in: PubMed
    Score: 0.011
  48. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther. 1989 Oct; 251(1):378-87.
    View in: PubMed
    Score: 0.010
  49. The acute histopathology of MPTP in the mouse CNS. Brain Res Bull. 1989 Jul-Aug; 23(1-2):1-17.
    View in: PubMed
    Score: 0.010
  50. Behavioral cross-sensitization between cocaine and enkephalin in the A10 dopamine region. Behav Brain Res. 1988 Jan; 27(1):87-91.
    View in: PubMed
    Score: 0.009
  51. Influence of cholecystokinin on central monoaminergic pathways. Regul Pept. 1983 May; 6(2):99-109.
    View in: PubMed
    Score: 0.006
  52. Interactions of neurotensin with brain dopamine systems. Ann N Y Acad Sci. 1982; 400:330-44.
    View in: PubMed
    Score: 0.006
  53. Response to intracerebral administration of cerebrospinal fluid in the pentobarbital pretreated rat. Neuropharmacology. 1980 May; 19(5):497-9.
    View in: PubMed
    Score: 0.005
  54. Thyrotropin-releasing hormone: central site of action in antagonism of pentobarbital narcosis. Nature. 1979 Mar 29; 278(5703):461-3.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.